List of Tables
Table 1. Global Oral Antiparkinsonian Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Antiparkinsonian Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Antiparkinsonian Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Antiparkinsonian Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Antiparkinsonian Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Antiparkinsonian Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Antiparkinsonian Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Antiparkinsonian Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Antiparkinsonian Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Antiparkinsonian Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Antiparkinsonian Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Oral Antiparkinsonian Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Antiparkinsonian Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antiparkinsonian Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Antiparkinsonian Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Antiparkinsonian Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Antiparkinsonian Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Oral Antiparkinsonian Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Antiparkinsonian Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Oral Antiparkinsonian Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Antiparkinsonian Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Antiparkinsonian Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Antiparkinsonian Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Antiparkinsonian Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Antiparkinsonian Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Antiparkinsonian Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Antiparkinsonian Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Antiparkinsonian Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Antiparkinsonian Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Antiparkinsonian Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Antiparkinsonian Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Antiparkinsonian Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Antiparkinsonian Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Antiparkinsonian Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Antiparkinsonian Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Antiparkinsonian Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Antiparkinsonian Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Antiparkinsonian Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Antiparkinsonian Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Antiparkinsonian Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Antiparkinsonian Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Antiparkinsonian Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Antiparkinsonian Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Oral Antiparkinsonian Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Oral Antiparkinsonian Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Oral Antiparkinsonian Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Oral Antiparkinsonian Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Oral Antiparkinsonian Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Antiparkinsonian Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Antiparkinsonian Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Antiparkinsonian Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Oral Antiparkinsonian Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Oral Antiparkinsonian Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Antiparkinsonian Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Antiparkinsonian Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Antiparkinsonian Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Oral Antiparkinsonian Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Antiparkinsonian Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Antiparkinsonian Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Oral Antiparkinsonian Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Oral Antiparkinsonian Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Antiparkinsonian Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Antiparkinsonian Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Antiparkinsonian Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AbbVie Oral Antiparkinsonian Drugs Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Oral Antiparkinsonian Drugs Product
Table 79. Merck Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Oral Antiparkinsonian Drugs Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. GlaxoSmithKline Company Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Oral Antiparkinsonian Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Novartis Pharma Company Information
Table 91. Novartis Pharma Description and Business Overview
Table 92. Novartis Pharma Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Pharma Oral Antiparkinsonian Drugs Product
Table 94. Novartis Pharma Recent Developments/Updates
Table 95. Supernus Pharmaceuticals Company Information
Table 96. Supernus Pharmaceuticals Description and Business Overview
Table 97. Supernus Pharmaceuticals Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Supernus Pharmaceuticals Oral Antiparkinsonian Drugs Product
Table 99. Supernus Pharmaceuticals Recent Developments/Updates
Table 100. Bausch Health Company Information
Table 101. Bausch Health Description and Business Overview
Table 102. Bausch Health Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bausch Health Oral Antiparkinsonian Drugs Product
Table 104. Bausch Health Recent Developments/Updates
Table 105. Newron Pharmaceuticals Company Information
Table 106. Newron Pharmaceuticals Description and Business Overview
Table 107. Newron Pharmaceuticals Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Newron Pharmaceuticals Oral Antiparkinsonian Drugs Product
Table 109. Newron Pharmaceuticals Recent Developments/Updates
Table 110. Teva Pharmaceutica Company Information
Table 111. Teva Pharmaceutica Description and Business Overview
Table 112. Teva Pharmaceutica Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutica Oral Antiparkinsonian Drugs Product
Table 114. Teva Pharmaceutica Recent Developments/Updates
Table 115. Glenmark Pharmaceuticals Company Information
Table 116. Glenmark Pharmaceuticals Description and Business Overview
Table 117. Glenmark Pharmaceuticals Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Glenmark Pharmaceuticals Oral Antiparkinsonian Drugs Product
Table 119. Glenmark Pharmaceuticals Recent Developments/Updates
Table 120. Orion Pharma Company Information
Table 121. Orion Pharma Description and Business Overview
Table 122. Orion Pharma Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Orion Pharma Oral Antiparkinsonian Drugs Product
Table 124. Orion Pharma Recent Developments/Updates
Table 125. Neurocrine Biosciences Company Information
Table 126. Neurocrine Biosciences Description and Business Overview
Table 127. Neurocrine Biosciences Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Neurocrine Biosciences Oral Antiparkinsonian Drugs Product
Table 129. Neurocrine Biosciences Recent Developments/Updates
Table 130. Kyowa Kirin Company Information
Table 131. Kyowa Kirin Description and Business Overview
Table 132. Kyowa Kirin Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Kyowa Kirin Oral Antiparkinsonian Drugs Product
Table 134. Kyowa Kirin Recent Developments/Updates
Table 135. UCB Company Information
Table 136. UCB Description and Business Overview
Table 137. UCB Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. UCB Oral Antiparkinsonian Drugs Product
Table 139. UCB Recent Developments/Updates
Table 140. Desitin Arzneimittel Company Information
Table 141. Desitin Arzneimittel Description and Business Overview
Table 142. Desitin Arzneimittel Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Desitin Arzneimittel Oral Antiparkinsonian Drugs Product
Table 144. Desitin Arzneimittel Recent Developments/Updates
Table 145. Amneal Pharmaceuticals Company Information
Table 146. Amneal Pharmaceuticals Description and Business Overview
Table 147. Amneal Pharmaceuticals Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Amneal Pharmaceuticals Oral Antiparkinsonian Drugs Product
Table 149. Amneal Pharmaceuticals Recent Developments/Updates
Table 150. Organon Pharma Company Information
Table 151. Organon Pharma Description and Business Overview
Table 152. Organon Pharma Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Organon Pharma Oral Antiparkinsonian Drugs Product
Table 154. Organon Pharma Recent Developments/Updates
Table 155. F.Hoffmann-La Roche Company Information
Table 156. F.Hoffmann-La Roche Description and Business Overview
Table 157. F.Hoffmann-La Roche Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. F.Hoffmann-La Roche Oral Antiparkinsonian Drugs Product
Table 159. F.Hoffmann-La Roche Recent Developments/Updates
Table 160. Lundbeck Company Information
Table 161. Lundbeck Description and Business Overview
Table 162. Lundbeck Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Lundbeck Oral Antiparkinsonian Drugs Product
Table 164. Lundbeck Recent Developments/Updates
Table 165. Stada Company Information
Table 166. Stada Description and Business Overview
Table 167. Stada Oral Antiparkinsonian Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Stada Oral Antiparkinsonian Drugs Product
Table 169. Stada Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Oral Antiparkinsonian Drugs Distributors List
Table 173. Oral Antiparkinsonian Drugs Customers List
Table 174. Oral Antiparkinsonian Drugs Market Trends
Table 175. Oral Antiparkinsonian Drugs Market Drivers
Table 176. Oral Antiparkinsonian Drugs Market Challenges
Table 177. Oral Antiparkinsonian Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Antiparkinsonian Drugs
Figure 2. Global Oral Antiparkinsonian Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Antiparkinsonian Drugs Market Share by Type: 2023 & 2030
Figure 4. L-Dopa Formulations Product Picture
Figure 5. Dopamine Agonists Product Picture
Figure 6. Mao-B Inhibitors Product Picture
Figure 7. COMT Inhibitors Product Picture
Figure 8. Global Oral Antiparkinsonian Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Oral Antiparkinsonian Drugs Market Share by Application: 2023 & 2030
Figure 10. Under 40 Years Old
Figure 11. 40-65 Years Old
Figure 12. Above 65 Years Old
Figure 13. Global Oral Antiparkinsonian Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Oral Antiparkinsonian Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Oral Antiparkinsonian Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Oral Antiparkinsonian Drugs Average Price (US$/Unit) & (2019-2030)
Figure 17. Oral Antiparkinsonian Drugs Report Years Considered
Figure 18. Oral Antiparkinsonian Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Oral Antiparkinsonian Drugs Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Oral Antiparkinsonian Drugs Players: Market Share by Revenue in Oral Antiparkinsonian Drugs in 2023
Figure 21. Oral Antiparkinsonian Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Oral Antiparkinsonian Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Oral Antiparkinsonian Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Oral Antiparkinsonian Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Oral Antiparkinsonian Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Oral Antiparkinsonian Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Oral Antiparkinsonian Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Oral Antiparkinsonian Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Oral Antiparkinsonian Drugs Sales Market Share by Country (2019-2030)
Figure 44. Mexico Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Oral Antiparkinsonian Drugs Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Oral Antiparkinsonian Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Oral Antiparkinsonian Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Oral Antiparkinsonian Drugs by Type (2019-2030)
Figure 54. Global Revenue Market Share of Oral Antiparkinsonian Drugs by Type (2019-2030)
Figure 55. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Oral Antiparkinsonian Drugs by Application (2019-2030)
Figure 57. Global Revenue Market Share of Oral Antiparkinsonian Drugs by Application (2019-2030)
Figure 58. Global Oral Antiparkinsonian Drugs Price (US$/Unit) by Application (2019-2030)
Figure 59. Oral Antiparkinsonian Drugs Value Chain
Figure 60. Oral Antiparkinsonian Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
